解读驱动癌症入侵和转移的分子途径:进展和治疗前景
Aziza Alshahrani1, Arwa Alsubait2,3, Zahrah Asiri4
1Department of Pharmacology, College of Pharmacy, King Khalid University, Abha, Saudi Arabia.
Frontiers in oncology
|December 18, 2025
概括
本综述探讨了驱动癌症转移的分子机制以及针对这些途径的创新疗法. 结合内在瘤可塑性和微环境支持的策略对于改善患者的治疗结果至关重要.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 翻译医学是一种翻译医学.
背景情况:
- 转移是全球癌症死亡的主要原因.
- 了解转移性进展的分子电路对于开发有效治疗方法至关重要.
研究的目的:
- 审查癌症转移的分子机制的最新进展.
- 检查针对转移途径的治疗创新.
- 讨论新兴的转移检测和治疗技术.
主要方法:
- 叙事审查整合了由专家指导的文献选择.
- 专注于分子电路:表皮-介质细胞过渡 (EMT),有机化,细胞外矩阵重塑,血管生成,缺氧诱导信号,迁移模式和瘤免疫相互作用.
- 分析治疗策略,包括EMT调节剂,MMP抑制剂,VEGF/VEGFR抑制剂,低氧激活前药物和免疫疗法.
主要成果:
- 在了解EMT,有机化和瘤免疫相互作用方面取得了进展.
- 开发有针对性的疗法,如EMT调节器,VEGF/VEGFR抑制剂和新型免疫疗法 (ICB,CAR T细胞).
- 新兴技术如纳米技术,多组学,单细胞分析和CRISPR-Cas9为转移管理提供了新的工具.
结论:
- 尽管取得了进展,但瘤内异质性和耐药性等挑战仍然存在.
- 以生物标志物为指导,多目标组合和跨学科合作是必不可少的.
- 针对瘤可塑性和微环境的综合策略是改变转移性癌症结果的关键.
相关概念视频
Metastasis
6.3K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Non-Canonical Wnt Signaling Pathways
8.2K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.2K
Canonical Wnt Signaling Pathway
10.3K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
10.3K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K


